Gene · 51455
Papers1,571
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,571
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein Assemblies in Translesion Synthesis. | Genes (Basel) | 2024 | 39062611 | PubTator, text mining | PubMed |
| PARP10 promotes the repair of nascent strand DNA gaps through RAD18 mediated translesion synthesis. | Nat Commun | 2024 | 39043663 | PubTator, text mining | PubMed |
| Loss-of-function mutation of REV1 (p.R704Q) mediates cetuximab primary resistance by activating autophagy in RAS-wild type metastatic colorectal cancer. | Cancer Lett | 2024 | 38969162 | PubTator, text mining | PubMed |
| Methylation and hydroxymethylation of cytosine alter activity and fidelity of translesion DNA polymerases. | DNA Repair (Amst) | 2024 | 38959714 | PubTator, text mining | PubMed |
| Comprehensive investigation of the mutagenic potential of six pesticides classified by IARC as probably carcinogenic to humans. | Chemosphere | 2024 | 38936485 | PubTator, text mining | PubMed |
| MRNIP limits ssDNA gaps during replication stress. | Nucleic Acids Res | 2024 | 38917325 | PubTator, text mining | PubMed |
| A cross-tissue transcriptome-wide association study reveals novel susceptibility genes for migraine. | J Headache Pain | 2024 | 38840241 | PubTator, text mining | PubMed |
| USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase. | J Biomed Sci | 2024 | 38802791 | PubTator, text mining | PubMed |
| Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction. | Bioorg Med Chem | 2024 | 38749343 | PubTator, text mining | PubMed |
| Primordial germ cell DNA demethylation and development require DNA translesion synthesis. | Nat Commun | 2024 | 38702312 | PubTator, text mining | PubMed |
| The Catalytic Activity of Human REV1 on Undamaged and Damaged DNA. | Int J Mol Sci | 2024 | 38612916 | Swiss-Prot, curated | PubMed |
| Rev1 overexpression accelerates N-methyl-N-nitrosourea (MNU)-induced thymic lymphoma by increasing mutagenesis. | Cancer Sci | 2024 | 38572512 | PubTator, text mining | PubMed |
| WRN exonuclease imparts high fidelity on translesion synthesis by Y family DNA polymerases. | Genes Dev | 2024 | 38503516 | PubTator, text mining | PubMed |
| RNA-catalyzed evolution of catalytic RNA. | Proc Natl Acad Sci U S A | 2024 | 38437533 | PubTator, text mining | PubMed |
| The levels of p53 govern the hierarchy of DNA damage tolerance pathway usage. | Nucleic Acids Res | 2024 | 38321962 | PubTator, text mining | PubMed |
| 8-Oxoadenine: A «New» Player of the Oxidative Stress in Mammals? | Int J Mol Sci | 2024 | 38279342 | PubTator, text mining | PubMed |
| APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. | Sci Adv | 2024 | 38241374 | PubTator, text mining | PubMed |
| Homozygous substitution of threonine 191 by proline in polymerase η causes Xeroderma pigmentosum variant. | Sci Rep | 2024 | 38212351 | PubTator, text mining | PubMed |
| What risk do Brucella vaccines pose to humans? A systematic review of the scientific literature on occupational exposure. | PLoS Negl Trop Dis | 2024 | 38190394 | PubTator, text mining | PubMed |
| PRIMPOL ensures robust handoff between on-the-fly and post-replicative DNA lesion bypass. | Nucleic Acids Res | 2024 | 37971291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51455/papers?page=3